GlaxoSmithKline Consumer Healthcare has informed that a meeting of the Board of Directors of the Company will be held on Friday, May 11, 2018 at 01:00 p.m. at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram 122 002 to consider and take on record the Audited Financial Results for the financial year ended March 31, 2018 and to consider Dividend for the financial year ended March 31, 2018.
The above information is a part of company’s filings submitted to BSE.
